Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, starboard value
Ex-Pfizer Top Execs Won’t Join Starboard’s Activist Campaign
Two former Pfizer top executives won’t participate in an activist investor’s effort to pressure the drugmaker to make changes to improve its performance.
Pfizer’s Former CEO Won’t Be Involved in Starboard Value Effort
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to statement released on their behalf late Wednesday.
Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
TMCnet
29m
Starboard Value Issues Letter to Pfizer's Board of Directors
Starboard Value LP (together with its affiliates, "Starboard" or "we"), a significant shareholder of Pfizer Inc. (NYSE: PFE) ("Pfizer" or the "Company"), today issued the below letter to Company's ...
3d
Starboard reportedly takes $1 billion stake in Pfizer, seeks changes
Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a ...
2d
Starboard Value takes $1 billion stake in Pfizer: Reports
An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...
2d
on MSN
Pfizer Stock Rises After It Gets an Activist. What Starboard’s Track Record With Pharma Tells Us.
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
2d
Pfizer goes from hunter to hunted as Starboard circles
With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Pfizer
Ian Read
COVID-19
Albert Bourla
Pharma
Feedback